• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 54

Substance: Xylanase derived from Fusarium venenatum carrying a gene encoding xylanase from Thermomyces lanuginosus
Intended Use: Use in the baking industry as a processing aid at minimum levels necessary in accordance with good manufacturing practices
Basis: Scientific procedures
Notifier: Novo Nordisk
77 Perry Chapel Church Road; Box 576; Franklinton, NC 27525
Date of filing: Jul 28, 2000
GRAS Notice (releasable information): 54
Date of closure: Feb 23, 2001
FDA's Letter: FDA has no questions